![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0052.jpg)
50
S
p eech
P
athology
A
ustralia
MULTICULTURALISM AND DYSPHAGIA
gastroenterology, otolaryngology, respiratory medicine, and a
specialist behavioural feeding team.
The plethora of medical issues that can predispose a patient
with 22q11DS to swallowing and feeding difficulties is
significant. With palatal/velopharyngeal, cardiac, gastro
intestinal and airway problems among the myriad of difficulties
reported, it is often difficult to determine which underlying
system is affecting feeding and/or swallowing, and therefore
how to provide appropriate management. In addition, altered
immune status leading to respiratory infections and use of
preventative medications to reduce infection may make
differential diagnosis of respiratory compromise resulting
from aspiration especially difficult.
When reviewing the literature on 22q11DS, “feeding
difficulties” are acknowledged, with a general agreement in
prevalence of 30–40% (McDonald-McGinn, 2004). Most papers,
however, are level 1 or 2 evidence, being case studies, expert
opinion, or anecdotal reports. The term “feeding difficulties”
is often poorly described, leaving the speech and language
therapist with little clarity as to their nature or aetiology.
Some papers, particularly earlier references, attribute these
problems to three of the main medical issues associated with
this condition – namely velopharyngeal dysfunction (VPD),
cardiac problems and gastro intestinal issues. It has been
suggested that feeding difficulties were often transient,
resolving within the first year of life (Devrient, Rommel, &
Casteels, 2005). Feeding difficulties are increasingly acknow
ledged as persistent, often requiring long term (over 1 year)
tube feeding (Eicher et al. 2000).
Some of the more common feeding difficulties, and
strategies for their management, are outlined below.
2
2q11.2 microdeletion syndrome (22q11DS) is reported to
be the second most common chromosomal abnormality
following Down syndrome. However, routine genetic testing
has only been available since the early 1990s, so it is likely
there are undiagnosed cases within the greater population.
Figures continue to increase, with an agreed incidence of
1:4,000 (McDonald-McGinn, 2004) and prevalence being
predicted as high as 1:1,600 (Shprintzen, 2008). This condition
is also known as DiGeorge syndrome, velocardiofacial syn
drome, conotruncal anomalies syndrome, Shprintzens
syndrome, Cayler cardiofacial syndrome, and less favourably,
“Catch 22”. The majority of patients are found to have a
common deletion band 11 on the long arm of the chromosome
22. 22q11 DS can be inherited in an autosomal dominant
fashion, however the majority (93%) of cases are not trans
mitted by either parent (McDonald-McGinn & Zackai, 2004).
With over 180 different medical difficulties currently
reported in this syndrome (VCFS foundation, 2007), patients
require comprehensive multidisciplinary management. No
single anomaly occurs in 100% of cases. McDonald-McGinn
(2004) reports the most common problems to be cardiac issues
(76%), velopharyngeal dysfunction (VPD) (76%), immuno
deficiency (77%) and hypocalcaemia (49%). Significantly
delayed motor and language development are also frequently
reported in this condition. Solot et al. (2001) found that 90% of
children presented with delayed language at 2 years. Typical
facial characteristics include narrow eyes, long face, cupped
ears and bulbous nose, though the facial features are often
subtle.
Early management is often, by necessity, medically focused
– on account, for example, of cardiac problems – with the
speech and language therapist’s (SLT) involvement often
centring on feeding and early communication. As the child
moves through the preschool years into the educational
setting, the SLT may continue to be involved with persistent
feeding problems, but often the main focus at this stage
moves to velopharyngeal function and speech and language.
In the older child, the balance shifts towards higher level
language and social communication. Difficulties in these areas
may be exacerbated by emerging psychological and
psychiatric problems.
The following two sections are authored by two speech
pathologists working in specialist centres with a focus on
22q11DS. Alex Forsyth provides information on dysphagia in
22qDS while Maeve Morrison outlines speech, language and
other developmental issues associated with this syndrome.
Dysphagia in 22q11DS
Alex Forsyth
At Great Ormond Street Hospital for Children in London,
United Kingdom, there are over 300 children on the speech
and language therapy caseload with a confirmed micro
deletion of 22q11.2 (22q11DS). These patients are monitored
closely by a multidisciplinary team, including paediatrics,
immunology, genetics, speech and language therapy and
clinical psychology. There are active links to other teams
within the wider hospital, including cleft lip and palate,
C
linical
I
nsights
22q11 Deletion Syndrome (Velocardiofacial Syndrome)
Alex Forsyth and Maeve Morrison
Mother and 2 daughters, all with 22q11 deletion syndrome
Mother was diagnosed with 22q11DS after her older daughter
was diagnosed as an infant. The mother had submucous cleft
palate repair at age 3 and pharyngoplasty at age 6. She now has
no evidence of speech disorder. Her older daughter, now aged 6,
has had pharyngoplasty which has improved speech clarity. The
younger daughter, aged 4 years, is currently being investigated
for VPD. She continues to depend on gastrostomy tube feeding
and has had frequent hospitalisation for respiratory and
cardiac concerns.
Note the subtle facial features which are typical in 22q11
deletion syndrome.